134 related articles for article (PubMed ID: 8185754)
1. Essential drugs should be accessible to all people.
Habiyambere V; Wertheimer AI
World Health Forum; 1993; 14(2):140-4. PubMed ID: 8185754
[TBL] [Abstract][Full Text] [Related]
2. Primary health care: from aspiration to achievement.
Diallo I; Molouba R; Sarr LC
World Health Forum; 1993; 14(4):349-55. PubMed ID: 8185783
[TBL] [Abstract][Full Text] [Related]
3. Health: building on the success of PHC in Africa.
Amaah SO
New Afr; 1989 Jul; (262):4, 6. PubMed ID: 12283696
[TBL] [Abstract][Full Text] [Related]
4. [Access for all to quality drugs].
Videau JY
Med Trop (Mars); 2002; 62(4):396-400. PubMed ID: 12534178
[TBL] [Abstract][Full Text] [Related]
5. U.S. blocks trade agreement on generic drug access in poor countries.
James JS
AIDS Treat News; 2002 Dec; (386):4-6. PubMed ID: 12569874
[TBL] [Abstract][Full Text] [Related]
6. Fees-for-services, cost recovery, and equity in a district of Burkina Faso operating the Bamako Initiative.
Ridde V
Bull World Health Organ; 2003; 81(7):532-8. PubMed ID: 12973646
[TBL] [Abstract][Full Text] [Related]
7. [Centralized purchasing of essential drugs, a priority for the health care systems of developing countries].
Blaise P; Dujardin B; de Béthune X; Vandenbergh D
Sante; 1998; 8(3):217-26. PubMed ID: 9690323
[TBL] [Abstract][Full Text] [Related]
8. Drug supply by ration kits: report of an evaluation.
Essent Drugs Monit; 1991; (11):12-4. PubMed ID: 12284332
[TBL] [Abstract][Full Text] [Related]
9. Prevention of disease the answer.
AIDS Wkly; 1994 Oct; ():14-5. PubMed ID: 12288413
[TBL] [Abstract][Full Text] [Related]
10. Limited access. Contraceptive costs may impede use.
Camp SL
Conscience; 1991; 12(6):12-3. PubMed ID: 12178843
[TBL] [Abstract][Full Text] [Related]
11. Effect of the Bamako-Initiative drug revolving fund on availability and rational use of essential drugs in primary health care facilities in south-east Nigeria.
Uzochukwu BS; Onwujekwe OE; Akpala CO
Health Policy Plan; 2002 Dec; 17(4):378-83. PubMed ID: 12424209
[TBL] [Abstract][Full Text] [Related]
12. Drugs--registration and marketing practices in the Third World.
Jayasena K
Dev Dialogue; 1985; (2):38-47. PubMed ID: 12341046
[TBL] [Abstract][Full Text] [Related]
13. [On misery coast. Episode 1: the market of vital drugs].
Chneiweiss H
Med Sci (Paris); 2003; 19(8-9):892-4. PubMed ID: 14593623
[No Abstract] [Full Text] [Related]
14. Global health and university patents.
Kapczynski A; Crone ET; Merson M
Science; 2003 Sep; 301(5640):1629. PubMed ID: 14500943
[No Abstract] [Full Text] [Related]
15. International regulation of the supply and use of pharmaceuticals.
Medawar C
Dev Dialogue; 1985; (2):15-37. PubMed ID: 12341045
[TBL] [Abstract][Full Text] [Related]
16. Dying with AIDS in Costa Rica. Access to care and treatment.
Stern R
AIDSlink; 1997; (45):14-5. PubMed ID: 12292735
[TBL] [Abstract][Full Text] [Related]
17. Drugs for the developing world.
GMHC Treat Issues; 1997-1998 Winter; 12(1):32. PubMed ID: 11364989
[TBL] [Abstract][Full Text] [Related]
18. Reprivatizing pharmaceutical supplies in Africa.
Turshen M
J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153
[TBL] [Abstract][Full Text] [Related]
19. Making drugs accessible.
Association La Bergerie
AIDS Action; 1999; (43):5. PubMed ID: 12349193
[TBL] [Abstract][Full Text] [Related]
20. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
Pablos-Mendez A; Gowda DK; Frieden TR
Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
